The global diabetic macular edema (DME) market is expected to reach a valuation of US$ 3.7 billion by the end of 2022, with a projected CAGR of 1.2% from 2022 to 2032, reaching a valuation of ~US$ 4.2 billion by the end of the forecast period, according to market research firm FMI. Despite a modest …
Tag Archives: Diabetic Macular Edema Market
Global Diabetic Macular Edema Industry is predicted to achieve a US$ 4.2 Billion valuation by 2032
By the end of 2022, the global diabetic macular edema industry size is predicted to be valued US$ 3.7 billion. From 2022 to 2032, it is projected to grow at a compound annual growth rate (CAGR) of 1.2%. By the end of 2032, the market is expected to be valued at approximately US$ 4.2 billion. …
Global Diabetic Macular Edema Market is Projected to Witness Steady Growth a CAGR Of 1.2%, To Reach a Valuation of US$ 4.2 Billion By 2032
The global Diabetic Macular Edema Market Size is expected to reach a valuation of US$ 3.7 Billion by the end of 2022, and further expand at a CAGR of 1.2% from 2022 to 2032. The market is projected to reach a valuation of ~US$ 4.2 Billion by the end of 2032. Anti-VEGF drugs are the current standard of care for DME, and they …
Diabetic Macular Edema Market are set to witness a CAGR of 1.2% and be valued at around US$ 4.2 Billion by 2032
The global Diabetic Macular Edema Market Size is expected to reach a valuation of US$ 3.7 Billion by the end of 2022, and further expand at a CAGR of 1.2% from 2022 to 2032. The market is projected to reach a valuation of ~US$ 4.2 Billion by the end of 2032. An Uptake of Intravitreal Implants by Patients to Drive Growth of the …